Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines

Abstract A majority of deep vein thromboses identified in screening studies of hospitalized patients remain clinically insignificant. Guidelines based on these studies markedly overestimate the risk of clinical venous thromboembolism (VTE) and the benefit of heparin prophylaxis. Accordingly, in 2012...

Full description

Bibliographic Details
Main Author: Andrew Kotaska
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Thrombosis Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12959-018-0180-6
id doaj-6b0e3fe06ca94d04be16e0388b9ee451
record_format Article
spelling doaj-6b0e3fe06ca94d04be16e0388b9ee4512020-11-25T01:50:30ZengBMCThrombosis Journal1477-95602018-10-011611810.1186/s12959-018-0180-6Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelinesAndrew Kotaska0Women’s & Children’s Health, Northwest Territories Health and Social Services Authority, Stanton Territorial HospitalAbstract A majority of deep vein thromboses identified in screening studies of hospitalized patients remain clinically insignificant. Guidelines based on these studies markedly overestimate the risk of clinical venous thromboembolism (VTE) and the benefit of heparin prophylaxis. Accordingly, in 2012, the American College of Chest Physicians (ACCP) removed screening studies from the 9th edition of its Antithrombotic and Thrombolytic Therapy guideline (AT9), and downgraded recommendations. Involvement of authors of the 8th edition (AT8) was restricted due to financial and intellectual conflicts of interest. However, the first author of AT8 subsequently wrote a “Getting Started Kit,” widely distributed to help Canadian hospitals develop VTE protocols. Based on screening studies reporting asymptomatic VTE, it lacks estimates of the magnitudes of benefit or harm from low molecular weight heparin (LMWH), yet advises prophylaxis in almost all hospitalized patients. Most Canadian hospitals have implemented guidelines based on this kit. Guidelines from the U. K National Institute for Health and Care Excellence and the U.S. Agency for Healthcare Research and Quality recommend a similar approach. However, a critical review of evidence reveals that most hospitalized patients have a risk of clinical VTE equal to or lower than the bleeding risk from LMWH. Most hospitalized patients should not receive LMWH until and unless randomized trials show more benefit than harm. Guidelines recommending liberal LMWH prophylaxis in hospitalized patients are not evidence based and should be critically re-examined.http://link.springer.com/article/10.1186/s12959-018-0180-6Venous thromboembolismProphylaxisGuidelinesEvidence-based medicineConflict of interestDeep vein thrombosis
collection DOAJ
language English
format Article
sources DOAJ
author Andrew Kotaska
spellingShingle Andrew Kotaska
Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines
Thrombosis Journal
Venous thromboembolism
Prophylaxis
Guidelines
Evidence-based medicine
Conflict of interest
Deep vein thrombosis
author_facet Andrew Kotaska
author_sort Andrew Kotaska
title Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines
title_short Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines
title_full Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines
title_fullStr Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines
title_full_unstemmed Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines
title_sort venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of canadian and international guidelines
publisher BMC
series Thrombosis Journal
issn 1477-9560
publishDate 2018-10-01
description Abstract A majority of deep vein thromboses identified in screening studies of hospitalized patients remain clinically insignificant. Guidelines based on these studies markedly overestimate the risk of clinical venous thromboembolism (VTE) and the benefit of heparin prophylaxis. Accordingly, in 2012, the American College of Chest Physicians (ACCP) removed screening studies from the 9th edition of its Antithrombotic and Thrombolytic Therapy guideline (AT9), and downgraded recommendations. Involvement of authors of the 8th edition (AT8) was restricted due to financial and intellectual conflicts of interest. However, the first author of AT8 subsequently wrote a “Getting Started Kit,” widely distributed to help Canadian hospitals develop VTE protocols. Based on screening studies reporting asymptomatic VTE, it lacks estimates of the magnitudes of benefit or harm from low molecular weight heparin (LMWH), yet advises prophylaxis in almost all hospitalized patients. Most Canadian hospitals have implemented guidelines based on this kit. Guidelines from the U. K National Institute for Health and Care Excellence and the U.S. Agency for Healthcare Research and Quality recommend a similar approach. However, a critical review of evidence reveals that most hospitalized patients have a risk of clinical VTE equal to or lower than the bleeding risk from LMWH. Most hospitalized patients should not receive LMWH until and unless randomized trials show more benefit than harm. Guidelines recommending liberal LMWH prophylaxis in hospitalized patients are not evidence based and should be critically re-examined.
topic Venous thromboembolism
Prophylaxis
Guidelines
Evidence-based medicine
Conflict of interest
Deep vein thrombosis
url http://link.springer.com/article/10.1186/s12959-018-0180-6
work_keys_str_mv AT andrewkotaska venousthromboembolismprophylaxismaycausemoreharmthanbenefitanevidencebasedanalysisofcanadianandinternationalguidelines
_version_ 1725001603681878016